News Press Releases March 30, 2021Exo Therapeutics Appoints Nagesh Mahanthappa to Board of Directors and Charles W. Roberts to Scientific Advisory Board December 16, 2020Exo Therapeutics Launches with $25 Million Series A Financing to Unlock Intractable Drug Targets with Exosites July 23, 2020A startup emerging from David Liu’s lab intends to commercialize a small-molecule enzyme inhibitor discovery platform to generate more potent drugs with higher specificity. We are a diverse group of scientists, researchers, and business leaders with the mission to develop a novel approach to medicines discovery with exosites. Careers
